CD4 and neoplasm: These results suggest that TDO2+ and TDO2– myofibroblasts differ in spatial distribution around tumor nests, in which TDO2+ myofibroblasts are located distally from tumor nests and possess a stronger capacity for chemotaxis toward CD4+ T cells and CD8+ T cells to shield tumor cells from T cell attacks in the TME.